Incidence and prevalence of hypercholesterolemia in Portugal: A systematic review. Part III;Incidência e prevalência da hipercolesterolemia em Portugal: Uma revisão sistemática da literatura. Parte III

Revista Portuguesa de Cardiologia

Volumn 22, Issue 6, 2003, Pages 829-836

  Costa, João ^a   Borges, Margarida ^a   Oliveira, Eduardo ^a   Gouveia, Miguel ^a   Carneiro, António Vaz ^a  

^a NONE

Author keywords

Cerebrovascular disease; Coronary disease; Dislipidemia; Evidence based cardiology; Hypercholesterolemia; Hypertriglyceridemia; Prevalence and incidence of disease; Stroke; Systematic review

Indexed keywords

ADULT; AGED; CALCULATION; DATA BASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDLINE; PORTUGAL; PREVALENCE; REVIEW;

EID: 0041317068     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. The World Health Report 2002. Reducing Risk and Promoting Healthy Life. (www.who.in/whr/2002/en/)
2. National Cholesterol Education Program. (http://www.nhlbi.nih.gov/about/ncep/index.htm) (http://www.doh.wa.gov/Publicat/96_HWS/cholhp5.pdf) (http://www.nhlbi.nih.gov/about/ncep/ncep_pd.htm)
3. National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. NIH Pub. No. 90-3046. Bethesda, MD: National Heart, Lung, and Blood Institute, 1990;139 pages.
4. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation 1991;83:2154-232.
5. National Cholesterol Education Program Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. Public Health Service - National Institutes of Health - National Heart, Lung, and Blood Institute National Cholesterol Education Program. NIH Publication No. 93-3047 Reprinted March, 1993
6. Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.
7. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
8. Grundy SM. Cholesterol and coronary heart disease: a new era. JAMA 1986;256:2849-58.
9. Stamler J, Wentworth D, Neaton JD, for the MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8.
10. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I: Reduction in the incidence of coronary heart disease. JAMA 1984;251:351-64.
11. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-74.
12. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Diseases 1978;31:201-306
13. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler HA. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990;322:1700-7.
14. Wong ND, Wilson PWF, Kannel WB. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. Ann Intern Med 1991;115:687-93.
15. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990;323:1112-9.
16. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Eng J Med. 1987;317:1237-45.
17. Shepherd J, Cobbe SM, Ford I, et al., for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Eng J Med. 1995;333:1301-7.
18. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and woman with average cholesterol levels: results of AFCAPS/TEXCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;179:1615-22.
19. Gordon DJ. Cholesterol lowering reduces mortality: the statins. In: Grundy SM, ed. Cholesterol-lowering therapy: evaluation of clinical trial evidence. New York: Marcel Dekker Inc., 2000:299-311.
20. Law MR, Wald NJ. Risk factor thresholds: their existence under scrutiny. BMJ. 2002 Jun 29;324(7353):1570-6.
21. Joshipura KJ et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001 Jun 19;134(12):1106-14.
22. Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet. 1998 Dec 5;352(9143):1801-7.
23. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol. 1980 Oct;46:649-54.
24. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Heart Protection Study Collaborative Group. Lancet 2002;360:7-22.
25. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Last review 19/11/200 (http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm)
26. Lipid Research Clinics population studies data book. Vol. 1. The prevalence study 1980 (National Institutes of Health Publication no. 80-1527). Washington: United States Government Printing Office, 1980;1-134.
27. Wilson PWF. The Epidemiology of Hypercholesterolemia: a global perspective. Am J Medicine 1989;87(Suppl 4A):5S-13S.
28. Gardner CD, Winkleby MA, Fortmann SP. Population Frequency Distribution of Non-High-Density Lipoprotein Cholesterol (Third National Health and Nutrition Examination Survey [NHANES III], 1988-1994). Am J Cardiol 2000;86:299-304.
29. Eisenberg S, Heiss G, Friedlander Y, et al. Comparison of plasma lipids, lipoproteins and dyslipoproteinemia in Israel and the United States: The Lipid Research Clinics Program Prevalence Study 1986;Vol 59:63-74.
30. Research Group ATS-RF2 of the Italian National Research Council: Distribution of some risk factors for atherosclerosis in nine Italian population samples. Am J Epidemiol 1981;113:338-46.
31. Klimov AN. Plasma lipids and lipoprotein cholesterol distributions: US-USSR Steering Committee for problem area I. USA-USSR First Lipoprotein Symposium (National Institutes of Health publication no. 83-1966). Washington: United States Government Printing Office 1982;303-20.
32. Holme I, Hjermann I, Helgeland A, Lung-Larsen PG, Leren P. Coronary risk factors and socioeconomic status. The Oslo study. Lancet 1976; II:1396-8.
33. Ducimetiere P, Cambien F, Richard JL, Rakotovao R, Claude JR. Coronary heart disease in middle-aged Frenchmen: comparisons between Paris Prospective study, seven countries study and pooling project. Lancet 1990; I:1346-50.
34. Williams OD, Rywik SL, Tyroler HA, et al. US Polish Pilot Study. In: USA-Poland Symposium: ischemic heart disease (National Institutes of Health publication no. 82-1273). Washington: United States Government Printing Office 1982;1-8.
35. Pocock SJ; Shaper AG; Philips AN; Walker M; Whitehead TP: High density lipoprotein cholesterol is not a major risk factor for ischemic heart disease in British men. Br Med J 1886;292:515-9.
36. Keys A; Coronary heart disease in seven countries. Circulation 1970;41 (Suppl 1):1-199.
37. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994 Hyattsville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics; 1994 DHHS publication n. (PHS) 94-1308.
38. Schwartz LM, Woloshin S. Changing disease definitions: implications for disease prevalence (analysis of the third national health and nutrition examination survey, 1988-1994). Effective Clinical Practice 1999;2:76-85.